Quarterly Result14 May 2026, 06:41 pm
Mangalam Drugs Approves FY26 Financial Results
AI Summary
Mangalam Drugs & Organics Ltd approved standalone and consolidated financial results for the quarter and year ended March 31, 2026, during its board meeting held on May 14, 2026. The statutory auditors have not expressed any modified opinions in their audit reports. The board meeting commenced at 12:30 P.M. and concluded at 3:45 P.M.
Key Highlights
- Audited financial results (standalone and consolidated) for FY26 approved.
- Audit report for FY26 does not contain modified opinions.
- Board meeting was held on May 14, 2026.
Price Impact
More from MANGALAM